A fall from grace: exposing the neurotoxicities of morphine

Abstract

Get full access to this article

View all access options for this article.

References

Woodward

Naraen

(2017) Opioid-induced myoclonus and hyperalgesia following a short course of low-dose oral morphine. Br J Pain 11: 32–35.

Stannard

(2011) Opioids for chronic pain: promise and pitfalls. Curr Opin Support Palliat Care 5: 150–157.

Lee

Silverman

Hansen

. (2011) A comprehensive review of opioid-induced hyperalgesia. Pain Physician 14: 145–161.

Roeckel

Le Coz

Gavériaux-Ruff

. (2016) Opioid-induced hyperalgesia: Cellular and molecular mechanisms. Neuroscience 338: 160–182.

Cregg

Russo

Gubbay

. (2013) Pharmacogenetics of analgesic drugs. Br J Pain. 7: 189–208.

Gretton

Ross

Rutter

. (2013) Plasma morphine and metabolite concentrations are associated with clinical effects of morphine in cancer patients. J Pain Symptom Manage 45: 670–680.

Kango Gopal

Hewton

Pazhvoor

(2014) Myoclonus associated with concomitant ciprofloxacin and oxycodone in an older patient. Br J Clin Pharmacol 77: 906–907.

Stone

Minton

(2011) European Palliative Care Research collaborative pain guidelines. Central side-effects management: what is the evidence to support best practice in the management of sedation, cognitive impairment and myoclonus? Palliat Med 25: 431–441.

Bannister

Dickenson

(2010) Opioid hyperalgesia Curr Opin Support Palliat Care 4: 1–5.

10.

Ahmedzai

(2013) Personalized medicine – one size fits one: Tailoring pain therapy to individuals’ needs. J Pain & Palliat Care Pharmacother 27: 83–85.